JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page. Anders Svenningsson - Sökfunktioner - Umeå universitet

Personalkatalog

Sök

Sök på:   

Lista institutioner och enheter i Institutioner och enheter i bokstavsordning sorteringsordning eller efter kategori sorteringsordning

Anders Svenningsson

Kontaktinformation

Befattning:

Överläkare

personbild

Verksam vid:

Farmakologi och klinisk neurovetenskap

Avdelning:

Klinisk neurovetenskap

Adress:

Umeå universitet
SE-901 85 Umeå
Sverige

Besöksadress:

Tel:

+46 90 785 19 33

E-postadress:

anders.svenningsson@neuro.umu.seE-post

Publikationer

Författare

Titel

År sorteringsordning

Fulltext

Svenningsson, Anders
Dring, Ann Marie
Fogdell-Hahn, Anna; et al.

Fatal neuroinflammation in a case of multiple sclerosis with anti-natalizumab antibodies
Neurology, 80(10): 965-967

2013

-

Svenningsson, Anders
Falk, Eva
Celius, Elisabeth G.; et al.

Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis: Results from the TYNERGY Trial: A Study in the Real Life Setting
PLoS ONE, 8(3): e58643-

2013

Hämta

Vågberg, Mattias
Kumlin, Urban
Svenningsson, Anders

Humoral immune response to influenza vaccine in natalizumab-treated MS patients
Neurological Research, 34(7): 730-733

2012

-

Holmen, C.
Piehl, F.
Hillert, J.; et al.

The 'Immunomodulation and Multiple Sclerosis Epidemiology' (IMSE) study: a Swedish nationwide pharmaco-epidemiological and genetic study focused on long-term safety and efficacy of natalizumab (Tysabri)
European Journal of Neurology, 19(SI, Suppl. 1): 751-751

2012

-

Svenningsson, Anders
Celius, Elisabeth
Schreiber, Karen; et al.

Natalizumab Reduces Fatigue as Measured by the Fatigue Scale for Motor and Cognitive Functions (FSMC) - First Results from the TYNERGY Trial
Neurology, 78(Suppl 1): P07081-

2012

-

Khademi, Mohsen
Dring, Ann
Gilthorpe, Jonathan; et al.

Multivariate analysis of inflammatory and neuronal injury markers in cerebrospinal fluid of multiple sclerosis: higher levels are associated with younger age
Journal of Neuroimmunology, 253(1-2): 100-100

2012

-

Gunnarsson, Martin
Malmeström, Clas
Axelsson, Markus; et al.

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
Annals of Neurology, 69(1): 83-89

2011

-

Holmén, Carolina
Piehl, Fredrik
Hillert, Jan; et al.

A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis
Multiple Sclerosis, 17(6): 708-719

2011

-

Olofsson, Sara
Wickström, Anne
Glenngard, Anna Huger; et al.

Effect of treatment with natalizumab on ability to work in people with multiple sclerosis productivity gain based on direct measurement of work capacity before and after 1 year of treatment
BioDrugs, 25(5): 299-306

2011

-

Salzer, Jonatan
Svenningsson, Anders
Sundström, Peter

Season of birth and multiple sclerosis in Sweden
Acta Neurologica Scandinavica, 122(1): 70-73

2010

-


Sidansvarig: Kerstin Gruffman
2010-11-02

Utskriftsversion